SEROQUEL XR 400 mg uzatýlmýþ salýnýmlý 60 tablet Ruhsat Bilgileri
AstraZeneca Türkiye İlaç Sanayi ve Ticaret Ltd.Şti.
[ 30 December 1899 ]
AstraZeneca Türkiye İlaç Sanayi ve Ticaret Ltd.Şti.
[ 30 December 1899 ]
AstraZeneca İlaç San. ve Tic. Ltd. Şti.
Büyükdere Cad. Yapı Kredi Plaza
B Blok Kat 3-4
Levent İstanbul
Tel: 0212 317 23 00
REFERANSLAR
1 SERM Clinical Overview, 2010- June, Shifts in Metabolic Factors. GEL locator: [CNS.000-301-989.2.0].
2 Clinical Overview, 2010-Feb-03, False Positive Results for Methadone and Tricyclic Antidepressants. GEL locator: [CNS.000-291-454.4.0].
3 SERM Clinical Overview, 2009-Dec-03, Decreased Haemoglobin. GEL locator: [CNS.000-288-813.2.0].
4 SERM Clinical Overview, 2010-June, Palpitations. GEL locator: [CNS.000-306-544.2.0].
5 SERM Clinical Overview, 2010-June, Changes in thyroid levels. GEL locator: [CNS.000-306 463.2.0].
6 SERM Clinical Overview, 2010-June, Dyspnea. GEL locator: [CNS.000-306-543.3.0].
7 SERM Clinical Overview, 2010-June, Somnambulism and other related disorders. GEL locator: [CNS.000-306-993.3.0].
8 SERM Clinical Overview, 2010- April, Decreased Neutrophil Count. GEL locator: [CNS.000-302-257.2.0].
SERM Clinical Overview, 2010-June, Overdose. GEL locator: [CNS.000-306-455.3.0]. Clinical Overview, 2009-Aug-7, Updated Suicidality Values. GEL locator: [CNS.000-294-843.2.0]. SERM Clinical Overview, 2009-Dec-03-CLEARS/Cataracts. GEL locator: [CNS.000-289-074.2.0]. International Clinical Overview, 2008-Mar-08, Quetiapine XR for treatment of depression and mania in bipolar disorder (see Table O 4 and following paragraph). GEL locator: [CNS.000-215-024.3.0].